Sanjay Shukla
Net worth: 91 671 $ as of 2026-06-29
Net worth: 91 671 $ as of 2026-06-29
Sanjay S.
Shukla is currently President, Chief Executive Officer & Director at aTyr Pharma, Inc. since 2017.
Formerly, Dr. Shukla was Chief Executive Officer at Rxmd, Inc. from 2009 to 2012 and Vice President & Head-Integrated Medical Services at Novartis AG from 2012 to 2015.
Education includes undergraduate and graduate degrees from the University of Maryland in 1994 and 1995, respectively, and a doctorate from Howard University College of Medicine in 2001.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ATYR PHARMA, INC. 0.16% | 2026-02-28 | 153,553 ( 0.16% ) | 91 671 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| ATYR PHARMA, INC. | Chief Executive Officer | 2017-10-31 |
| Companies | Position | End |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 2015-03-31 |
Rxmd, Inc. | Chief Executive Officer | 2012-08-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Howard University College of Medicine
Howard University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rxmd, Inc. |
Select your edition
All financial news and data tailored to specific country editions